Loading stock data…
Oscar Health, Inc. (OSCR)
$28.19-0.73 (-2.52%)
Market ClosedLast close Jul 24
Oscar Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Oscar Health, Inc. in the Healthcare sector is trading at $28.19 with a market capitalization of $6.2B. Wall Street consensus targets $24.20 (10 analysts), implying a -14.2% move over the next 12 months. The stock is currently 15% below its 52-week high of $33.10, remaining 50.9% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply -14.2% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 34) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.65B↑ | $2.81B↓ | $2.99B↑ | $2.86B↓ | $3.05B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $704.16M↑ | -$353.78M↓ | -$132.43M↑ | -$227.69M↓ | $294.20M |
| Net Income | $679.00M↑ | -$352.61M↓ | -$137.45M↑ | -$228.36M↓ | $275.27M |
Peer Comparison
JNJUNHPFE
Fundamentals
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healt...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$6.18B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.34
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-2.37%
Volume
Today's trading volume
2.45M
Recent News
Has Oscar Health (OSCR) Run Too Far After Its 68% 90 Day Rally?
Oscar Health (OSCR) has been drawing attention after a strong share price run, with investors weighing that performance against mixed valuation signals that suggest the stock is not an obvious bargain. See our latest analysis for Oscar Health. Recent trading has cooled slightly, with the share price down around 3% over the past month and 7 days. That comes after a strong 90 day share price return of about 68% and a very large 3 year total shareholder return, suggesting momentum has been...
1 Surging Stock to Own for Decades and 2 We Find Risky
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
Oscar Health (OSCR) Stock Still Looks Undervalued As Its 270% Run Raises Questions
Oscar Health stock has delivered very strong returns over the past few years, yet the valuation checks present a more mixed picture that stops short of calling it a straightforward bargain. The share price has returned 269.8% over the last 3 years, which puts recent short term pullbacks into the context of a powerful longer term move. Investor expectations around Oscar Health's ability to scale its insurance platform efficiently can support the current valuation, while ongoing execution...
Oscar Health, Inc. (OSCR) Registers a Bigger Fall Than the Market: Important Facts to Note
Oscar Health, Inc. (OSCR) reached $29.5 at the closing of the latest trading day, reflecting a -4.13% change compared to its last close.
Goosehead Insurance (GSHD) Q2 Earnings and Revenues Beat Estimates
Goosehead (GSHD) delivered earnings and revenue surprises of +23.08% and +9.70%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?